Opinion
Video
Author(s):
Expert clinicians offer strategic guidance on optimal sequencing of antibody-drug conjugates (ADCs) in treatment protocols.
More Precise Classifications of Non–Clear Cell RCC Are Required to Improve Personalized Treatment
Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress
Histologic Features, Risk Help Reduce Uncertainties Around Frontline Treatment Selection in RCC
Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions
New Research Shows CDK5–Cyclin B1 Regulates Mitotic Fidelity
New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants
Dr Hiltermann on ARTEMIDE-01 Data With Rilvegostomig in Metastatic NSCLC
Amivantamab Plus Lazertinib Delays Symptomatic Progression in EGFR+ Advanced NSCLC
T-DXd Displays Clinical Benefit in HER2-Overexpressed Metastatic NSCLC
Dr Besse on Results From the CARMEN-LC03 Trial in Nonsquamous NSCLC